Bristol Myers Squibb (BMY) Treasury Shares (2009 - 2026)

Bristol Myers Squibb (BMY) has reported Treasury Shares for 18 consecutive years, with $43.5 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Treasury Shares changed 0.2% year-over-year to $43.5 billion in Q2 2026; TTM through Jun 2026 was $43.5 billion, a 0.2% change from a year earlier, with the FY2025 full-year figure at $43.6 billion, changed 0.17% from the prior year.
• Treasury Shares was $43.5 billion for Q2 2026 at Bristol Myers Squibb, roughly flat from $43.5 billion in the prior quarter.
• Over five years, Treasury Shares peaked at $902.0 million in Q4 2023 and troughed at $788.0 million in Q2 2022.
• A 5-year average of $863.7 million and a median of $887.0 million in 2025 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares grew 29.37% in 2022 and fell 0.25% in 2024, its largest moves.
• Over 5 years, Treasury Shares stood at $38.6 billion in 2022, then rose by 13.33% to $43.8 billion in 2023, then declined by 0.25% to $43.7 billion in 2024, then dropped by 0.17% to $43.6 billion in 2025, then decreased by 0.17% to $43.5 billion in 2026.
• The last three Treasury Shares figures came in at $43.5 billion (Q2 2026), $43.5 billion (Q1 2026), and $43.6 billion (Q4 2025), per Business Quant data.